| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $41.4M | +12.3% |
| Cost of Revenue | $23.9M | +24.2% |
| Gross Profit | $17.5M | -0.8% |
| R&D Expense | $7.7M | +79.4% |
| SG&A Expense | $28.3M | +38.8% |
| Operating Income | -$49.7M | -313.5% |
| Pre-tax Income | -$49.4M | -290.8% |
| Income Tax | -$1.9M | +32.1% |
| Net Income | -$47.5M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $4.3M | -8.7% |
| Inventory | $12.2M | +127.0% |
| Current Assets | $61.1M | -39.6% |
| Total Assets | $152.3M | -8.6% |
| Current Liabilities | $10.9M | +40.4% |
| Long-term Debt | $22.0M | +85.1% |
| Total Liabilities | $52.4M | +124.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.4M | -202.1% |
| Capital Expenditures | $28.1M | +41.6% |
| Investing Cash Flow | -$28.1M | -60.7% |
| Financing Cash Flow | $10.3M | -90.7% |
| Free Cash Flow | -$55.5M | -91.9% |
| -384.2% |
| EPS (Basic) | -$1.69 | -177.0% |
| EPS (Diluted) | -$1.69 | -177.0% |
| Stockholders' Equity |
| $99.9M |
| -30.2% |